NCT04079530View on ClinicalTrials.gov

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

December 24, 2019

Study Completion Date

December 24, 2019

Conditions
Dyslipidemias
Interventions
DRUG

K-877 IR 0.2 mg/day

K-877 IR 0.1 mg tablet

DRUG

K-877 CR 0.4 mg/day

K-877 CR 0.4 mg tablet

DRUG

K-877 CR 0.8 mg/day

Two K-877 CR 0.4 mg tablet

Trial Locations (1)

532-0003

Medical Corporation Heishinkai OPHAC Hospital, Osaka

All Listed Sponsors
lead

Kowa Company, Ltd.

INDUSTRY

NCT04079530 - A Clinical Pharmacology Study of K-877 Controlled Release Tablet | Biotech Hunter | Biotech Hunter